PE/Cyanine7 anti-mouse CD8a [53-6.7] and 6 more items

BioLegend Inc. was awarded contract A207_PO-0450913 by the University of Virginia on June 19, 2026, with a cumulative value of $1,128.45. The contract covers the procurement of seven distinct monoclonal antibody reagents for flow cytometry applications, including PE/Cyanine7 anti-mouse CD8a, PE/Cyanine7 anti-mouse CD127, Brilliant Violet 421 anti-mouse CD335, PerCP/Cyanine5.5 anti-mouse/human CD11b, Brilliant Violet 421 anti-mouse CD326, Brilliant Violet 421 anti-mouse CD11c, and APC anti-mouse CD4. All line items specify a quantity of one unit each, with individual unit prices ranging from $73.50 to $288.75.

All deliverables under this contract are designated for delivery to Carrie Adeline Cowardin at the University of Virginia in Virginia. The contract represents a straightforward materials procurement for research purposes, with the monoclonal antibody reagents serving as essential tools for immunological analysis and cell characterization in laboratory settings. No specific performance period beyond the award date of June 19, 2026, is documented in the contract record.